EDP Sciences logo
Authentification abonné
Rechercher
Menu
Accueil Tous les numéros Volume 33 / Numéro 1 (Janvier 2017) Med Sci (Paris), 33 1 (2017) 25-31 Références
Accès gratuit
Numéro
Med Sci (Paris)
Volume 33, Numéro 1, Janvier 2017
Matériaux pour la médecine de demain
Page(s) 25 - 31
Section M/S Revues
DOI https://doi.org/10.1051/medsci/20173301005
Publié en ligne 25 janvier 2017
  1. Katsumori T, Kasahara T. The size of gelatin sponge particles: differences with preparation method. Cardiovasc Intervent Radiol 2006 ; 29 : 1077–1083. [CrossRef] [PubMed] [Google Scholar]
  2. Abada HT, Golzarian J. Gelatine sponge particles: handling characteristics for endovascular use. Tech Vasc Interv Radiol 2007 ; 10 : 257–260. [CrossRef] [PubMed] [Google Scholar]
  3. Laurent A, Wassef M, Saint Maurice JP, et al. Arterial distribution of calibrated tris-acryl gelatin and polyvinyl alcohol microspheres in a sheep kidney model. Invest Radiol 2006 ; 41 : 8–14. [Google Scholar]
  4. Forsberg JO. Transient blood flow reduction induced by intra-arterial injection of degradable starch microspheres. Experiments on rats. Acta Chir Scand 1978 ; 144 : 275–281. [Google Scholar]
  5. Wasser K, Giebel F, Fischbach R, et al. Transarterial chemoembolization of liver metastases of colorectal carcinoma using degradable starch microspheres (Spherex®): personal investigations and review of the literature. Radiology 2005 ; 45 : 633–643. [EDP Sciences] [Google Scholar]
  6. Owen RJ, Nation PN, Polakowski R, et al. A preclinical study of the safety and efficacy of Occlusin 500 artificial embolization device in sheep. Cardiovasc Intervent Radiol 2012 ; 35 : 636–644. [CrossRef] [PubMed] [Google Scholar]
  7. Ohta S, Nitta N, Takahashi M, et al. Degradable gelatin microspheres as an embolic agent: an experimental study in a rabbit renal model. Korean J Radiol 2007 ; 8 : 418–428. [CrossRef] [PubMed] [Google Scholar]
  8. Ohta S, Nitta N, Watanabe S, et al. Gelatin microspheres: correlation between embolic effect/degradability and cross-linkage/particle size. Cardiovasc Intervent Radiol 2013 ; 36 : 1105–1111. [CrossRef] [PubMed] [Google Scholar]
  9. Tabata Y, Ikada Y. Synthesis of gelatin microspheres containing interferon. Pharm Res 1989 ; 6 : 422–427. [CrossRef] [PubMed] [Google Scholar]
  10. Weng L, Le HC, Talaie R, Golzarian J. Bioresorbable hydrogel microspheres for transcatheter embolization: preparation and in vitro evaluation. J Vasc Interv Radiol 2011 ; 22 : 1464–1470. [CrossRef] [PubMed] [Google Scholar]
  11. Weng L, Rusten M, Talaie R, et al. Calibrated bioresorbable microspheres: a preliminary study on the level of occlusion and arterial distribution in a rabbit kidney model. J Vasc Interv Radiol 2013 ; 24 : 1567–1575. [CrossRef] [PubMed] [Google Scholar]
  12. Weng L, Seelig D, Rostamzadeh P, Golzarian J. Calibrated bioresorbable microspheres as an embolic agent: an experimental study in a rabbit renal model. J Vasc Interv Radiol 2015 ; 26 : 1887–1894. [CrossRef] [PubMed] [Google Scholar]
  13. Weng L, Le HC, Lin J, Golzarian J. Doxorubicin loading and eluting characteristics of bioresorbable hydrogel microspheres: in vitro study. Int J Pharm 2011 ; 409 : 185–193. [CrossRef] [PubMed] [Google Scholar]
  14. Weng L, Rostamzadeh P, Nooryshokry N, et al. In vitro and in vivo evaluation of biodegradable embolic microspheres with tunable anticancer drug release. Acta Biomater 2013 ; 9 : 6823–6833. [CrossRef] [PubMed] [Google Scholar]
  15. Schwarz A, Zhang H. Embolization using degradable crosslinked hydrogels. Brevet WO/03/094930, novembre 2003. [Google Scholar]
  16. Schwarz A, Zhang H, Metcalfe A, et al. Transcatheter embolization using degradable crosslinked hydrogels. Biomaterials 2004 ; 25 : 5209–5215. [CrossRef] [PubMed] [Google Scholar]
  17. Brandom D, Schmid E, Zeltinger J, et al. Inherently radiopaque polymeric products for embolotherapy. Brevet WO/2005/030268, avril 2005. [Google Scholar]
  18. Louguet S, Verret V, Bédouet L, et al. Poly(ethylene glycol) methacrylate hydrolyzable microspheres for transient vascular embolization. Acta Biomater 2014 ; 10 : 1194–1205. [CrossRef] [PubMed] [Google Scholar]
  19. Bédouet L, Verret V, Louguet S, et al. Anti-angiogenic drug delivery from hydrophilic resorbable embolization microspheres: an in vitro study with sunitinib and bevacizumab. Int J Pharm 2015 ; 484 : 218–227. [CrossRef] [PubMed] [Google Scholar]
  20. Maeda N, Verret V, Moine L, et al. Targeting and recanalization after embolization with calibrated resorbable microspheres versus hand-cut gelatin sponge particles in a porcine kidney model. J Vasc Interv Radiol 2013 ; 24 : 1391–1398. [CrossRef] [PubMed] [Google Scholar]
  21. Verret V, Pelage JP, Wassef M, et al. A novel resorbable embolization microsphere for transient uterine artery occlusion: a comparative study with trisacryl-gelatin microspheres in the sheep model. J Vasc Interv Radiol 2014 ; 25 : 1759–1766. [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.